[2,2-联吡啶]-3-羧酸 | 220340-46-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: [2,2-联吡啶]-3-羧酸
• 中文别名: 2,2 - 联吡啶-3 - 羧酸
• 英文名称: 2,2'-bipyridine-3-carboxylic acid
• 英文别名: [2,2'-Bipyridine]-3-carboxylic acid；2-pyridin-2-ylpyridine-3-carboxylic acid
• CAS: 220340-46-5
• 化学式: C₁₁H₈N₂O₂
• 分子量: 200.197
• InChiKey: OQVVVVYHNKQXHR-UHFFFAOYSA-N

物化性质

• 沸点：
  372.7±27.0 °C(Predicted)
• 密度：
  1.302±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.1
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  [2,2-联吡啶]-3-羧酸 在 草酰氯 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 2.0h， 生成 2-Pyridin-2-ylpyridine-3-carbonyl chloride
  参考文献：
  名称：

  二硫键官能化的3、4、5和6取代的2,2'-联吡啶及其钌配合物。

  摘要：

  DOI：

  10.1021/jo9814795
• 作为产物：
  描述：

  2-(三甲基甲锡烷基)吡啶 在 bis-triphenylphosphine-palladium(II) chloride sodium hydroxide 作用下， 以 1,4-二氧六环 、 甲醇 为溶剂， 反应 16.0h， 生成 [2,2-联吡啶]-3-羧酸
  参考文献：
  名称：

  二硫键官能化的3、4、5和6取代的2,2'-联吡啶及其钌配合物。

  摘要：

  DOI：

  10.1021/jo9814795

文献信息

• [EN] FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS THIAZOLE ET THIOPHÈNE FUSIONNÉS COMME INHIBITEURS DE KINASE
  申请人：UCB PHARMA SA

  公开号：WO2009071895A1

  公开（公告）日：2009-06-11

  A series of fused bicyclic thiazole and thiophene derivatives which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, and in the 4-position by hydroxy, oxo or an amine moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. (I)

  一系列在2位被一个可选择取代的吗啡啉-4-基团取代，并在4位被羟基、酮基或胺基团取代的融合双环噻唑和噻吩衍生物，作为选择性PI3激酶酶抑制剂，在医学上具有益处，例如在治疗炎症、自身免疫、心血管、神经退行性、代谢、肿瘤、疼痛或眼科疾病方面。（I）
• [EN] TRICYCLIC KINASE INHIBITORS<br/>[FR] INHIBITEURS TRICYCLIQUES DE KINASE
  申请人：UCB PHARMA SA

  公开号：WO2009071890A1

  公开（公告）日：2009-06-11

  A series of fused tricyclic thiazole and thiophene derivatives which are substituted in the 2-position of the thiazole or thiophene ring by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.

  一系列融合的三环噻唑和噻吩衍生物，其在噻唑或噻吩环的2位被一个可选择取代的吗啡啉-4-基团取代，是选择性PI3激酶酶抑制剂，在医学上具有益处，例如在治疗炎症性、自身免疫性、心血管、神经退行性、代谢性、肿瘤学、疼痛性或眼科疾病方面。
• Preparation of aromatic and heteroaromatic carboxylic acids by catalytic ozonolysis
  申请人：——

  公开号：US20030216577A1

  公开（公告）日：2003-11-20

  A process for catalytically oxidizing alkylaromatic compounds of the formula (I) Ar—CH 2 —R where Ar is an optionally substituted, aromatic or heteroaromatic 5-membered or 6-membered ring or a ring system having up to 20 carbon atoms where Ar may optionally be fused to a C 1 -C 6 -alkyl group in which up to 2 carbon atoms may be replaced by a heteroatom, and R is hydrogen, phenyl, benzyl or heteroaryl, where the phenyl, benzyl or heteroaryl radicals may also be joined to Ar by a bridge, or R together with Ar forms an optionally substituted ring system which may contain one or more optionally substituted heteroatoms, to the corresponding aromatic or heteroaromatic carboxylic acids in a solvent with ozone in the presence of a transition metal catalyst and optionally in the presence of an acid at a temperature between −70° C. and 110° C. to the corresponding carboxylic acid.

  将式(I)中的烷基芳香化合物催化氧化为相应的芳香或杂芳羧酸的过程是在溶剂中，在存在过渡金属催化剂和可选地存在酸的情况下，利用臭氧将式(I)中的化合物氧化为相应的芳香或杂芳羧酸的过程。其中，式(I)中Ar为可选地取代的芳香或杂芳5-或6-成员环或具有多达20个碳原子的环系统，其中Ar可选地与一个C1-C6-烷基基团融合，其中最多有2个碳原子可被杂原子取代；R为氢、苯基、苄基或杂芳基，其中苯基、苄基或杂芳基基团也可以通过桥连接到Ar，或R与Ar一起形成一个可选地取代的环系统，该环系统可以含有一个或多个可选地取代的杂原子，反应温度在-70°C至110°C之间。
• [EN] PYRIDINE COMPOUNDS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV<br/>[FR] COMPOSES PYRIDINES UTILISES COMME INHIBITEURS DE DIPEPTIDYLE PEPTIDASE IV
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2005042488A1

  公开（公告）日：2005-05-12

  A compound represented by the formula wherein R1 and R2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted hydroxy group; R3 is an optionally substituted aromatic group; R4 is an optionally substituted amino group; L is a divalent chain hydrocarbon group; Q is a bond or a divalent chain hydrocarbon group; and X is a hydrogen atom, a cyano group, a nitro group, an acyl group, a substituted hydroxy group, an optionally substituted thiol group, an optionally substituted amino group or an optionally substituted cyclic group; provided that when X is an ethoxycarbonyl group, then Q is a divalent chain hydrocarbon group. The compound has a peptidase inhibitory action, is useful as an agent for the prophylaxis or treatment of diabetes and the like, and is superior in efficacy, duration of action, specificity, lower toxicity and the like.

  该化合物的化学式表示为其中R1和R2相同或不同，每个都是可选择取代的碳氢基团或可选择取代的羟基团；R3是可选择取代的芳香基团；R4是可选择取代的氨基团；L是二价链状碳氢基团；Q是键或二价链状碳氢基团；X是氢原子、氰基、硝基、酰基、取代的羟基团、可选择取代的硫醇基团、可选择取代的氨基团或可选择取代的环状基团；但当X是乙氧羰基团时，Q为二价链状碳氢基团。该化合物具有肽酶抑制作用，可用作糖尿病等疾病的预防或治疗药物，并在功效、作用持续时间、特异性、毒性较低等方面具有优越性。
• Novel bipyridine derivatives
  申请人：Kuwabara Hirokazu

  公开号：US20050085642A1

  公开（公告）日：2005-04-21

  The invention provides a bipyridine derivative useful as an intermediate for pharmaceutical products, agricultural chemicals, electrophotographic photosensitive materials, dyes and the like, which is a bipyridine derivative represented by the general formula (I) and a salt thereof: wherein R1 represents an alkyl group with 2 to 20 carbon atoms having a substituent, substituted or unsubstituted aminomethyl group, trifluoromethyl group, substituted or unsubstituted thiomethyl group, substituted or unsubstituted alkenyl group, substituted or unsubstituted alkoxy group, substituted or unsubstituted aryloxy group, substituted carbonyl group, substituted sulfonyl group, unsubstituted or monosubstituted carbamoyl group, unsubstituted or monosubstituted sulfamoyl group, substituted or unsubstituted thiol group, unsubstituted or monosubstituted amino group, substituted carbonylamino group, substituted or unsubstituted ureido group, nitro group, cyano group, formyl group or an equivalent thereof, iodine atom or fluorine atom.

  该发明提供了一种对制药产品、农药化学品、电子感光材料、染料等具有中间体作用的双吡啶衍生物，其为一种由通式（I）表示的双吡啶衍生物及其盐：其中R1代表具有取代基的2至20个碳原子的烷基基团，取代或未取代氨甲基基团，三氟甲基基团，取代或未取代硫甲基基团，取代或未取代烯基基团，取代或未取代烷氧基团，取代或未取代芳氧基团，取代羰基团，取代磺酰基团，未取代或单取代的氨甲酰基团，未取代或单取代的磺酰胺基团，取代或未取代硫醇基团，未取代或单取代的氨基团，取代羰基氨基团，取代或未取代脲基团，硝基基团，氰基团，甲酰基团或其等效物，碘原子或氟原子。